Table 1.
2TCM | BP Logan | BP SRTM | |||
---|---|---|---|---|---|
|
|
|
|||
BP ND (k 3/k 4) | ROI-based numerical approach | Image-derived approach presented | ROI-based numerical approach | Image-derived approach presented | |
Putamen | 7.6 ± 0.37 | 6.7 ± 0.22 | 6.3 ± 0.29 | 6.4 ± 0.12 | 6.5 ± 0.16 |
%COV | 4.9 | 3.3 | 4.6 | 1.9 | 2.5 |
Caudate | 7.9 ± 0.49 | 6.8 ± 0.25 | 6.4 ± 0.18 | 6.5 ± 0.16 | 6.6 ± 0.16 |
%COV | 6.2 | 3.7 | 2.8 | 2.5 | 2.4 |
Midbrain | 1.8 ± 0.14 | 1.5 ± 0.11 | 1.4 ± 0.13 | 1.5 ± 0.13 | 1.6 ± 0.16 |
%COV | 7.8 | 74.0 | 9.3 | 8.7 | 10.0 |
Thalamus | 0.87 ± 0.09 | 0.60 ± 0.07 | 0.60 ± 0.06 | 0.50 ± 0.15 | 0.60 ± 0.10 |
%COV | 10.3 | 11.7 | 10.0 | 30.0 | 16.7 |
Temporal | 0.63 ± 0.14 | 0.14 ± 0.07 | 0.13 ± 0.07 | 0.12 ± 0.03 | 0.14 ± 0.04 |
%COV | 22.2 | 50.0 | 53.8 | 25.0 | 28.6 |
2TCM: two-tissue compartment model; BP ND: binding potential (k 3/k 4) obtained by kinetic analysis of the 2TCM using arterial plasma input; BP Logan: binding potential obtained by the Logan DVR approach; BP SRTM: binding potential obtained by the simplified reference tissue model; %COV: percent coefficient of variance; Values are mean ± s.d.